National Plan to Address Alzheimer’s Disease: 2021 Update

On January 4, 2011, the National Alzheimer’s Project Act (NAPA) (Public Law 111-375) was signed into law. The Act defines “Alzheimer’s” as Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) and requires the Secretary of the U.S. Department of Health and Human Services (HHS) to establish the National Alzheimer’s Project to:

• Create and maintain an integrated National Plan to overcome Alzheimer’s disease;
• Coordinate Alzheimer’s disease research and services across all federal agencies;
• Accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer’s disease;
• Improve early diagnosis and coordination of care and treatment of Alzheimer’s disease;
• Decrease disparities in Alzheimer’s disease for racial and ethnic minority populations that are at higher risk for Alzheimer’s disease; and,
• Coordinate with international bodies to fight Alzheimer’s disease globally.

The law also establishes the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council) and requires the Secretary of HHS, in collaboration with the Advisory Council, to create and maintain a National Plan to overcome AD/ADRD.

Click here to download the NAPA 2021 Update.